658 related articles for article (PubMed ID: 18996161)
21. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine.
Wu CJ; Lee SC; Huang HW; Tao MH
Vaccine; 2004 Mar; 22(11-12):1457-64. PubMed ID: 15063569
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
23. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
24. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
[TBL] [Abstract][Full Text] [Related]
26. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine.
Nam JH; Cha SL; Cho HW
Microbiol Immunol; 2002; 46(1):23-8. PubMed ID: 11911185
[TBL] [Abstract][Full Text] [Related]
28. A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice.
Wu Y; Zhang F; Ma W; Song J; Huang Q; Zhang H
Microbiol Immunol; 2004; 48(8):585-90. PubMed ID: 15322338
[TBL] [Abstract][Full Text] [Related]
29. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
[TBL] [Abstract][Full Text] [Related]
30. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
Pugachev KV; Mason PW; Shope RE; Frey TK
Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
[TBL] [Abstract][Full Text] [Related]
31. Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.
Pan CH; Chen HW; Huang HW; Tao MH
J Virol; 2001 Dec; 75(23):11457-63. PubMed ID: 11689627
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
33. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
[TBL] [Abstract][Full Text] [Related]
34. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
[TBL] [Abstract][Full Text] [Related]
35. Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies.
Rauthan M; Kaur R; Appaiahgari MB; Vrati S
Microbes Infect; 2004 Nov; 6(14):1305-11. PubMed ID: 15555537
[TBL] [Abstract][Full Text] [Related]
36. Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models.
Xu XG; Wang ZS; Zhang Q; Li ZC; Zhao HN; Li W; Tong DW; Liu HJ
Vaccine; 2011 Jan; 29(4):636-43. PubMed ID: 21115062
[TBL] [Abstract][Full Text] [Related]
37. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
[TBL] [Abstract][Full Text] [Related]
38. Baker's yeast expressing the Japanese encephalitis virus envelope protein on its cell surface: induction of an antigen-specific but non-neutralizing antibody response.
Upadhyaya B; Manjunath R
Yeast; 2009 Jul; 26(7):383-97. PubMed ID: 19504623
[TBL] [Abstract][Full Text] [Related]
39. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice.
Wei JC; Huang YZ; Zhong DK; Kang L; Ishag H; Mao X; Cao RB; Zhou B; Chen PY
Biochem Biophys Res Commun; 2010 Jun; 396(4):787-92. PubMed ID: 20457131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
